167 related articles for article (PubMed ID: 15945298)
41. Efficacy of add-on aldosterone receptor blocker in uncontrolled hypertension.
Sharabi Y; Adler E; Shamis A; Nussinovitch N; Markovitz A; Grossman E
Am J Hypertens; 2006 Jul; 19(7):750-5. PubMed ID: 16814132
[TBL] [Abstract][Full Text] [Related]
42. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
Makkar KM; Sanoski CA; Spinler SA
Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
[TBL] [Abstract][Full Text] [Related]
43. Salt, aldosterone and hypertension.
Pimenta E; Gordon RD; Stowasser M
J Hum Hypertens; 2013 Jan; 27(1):1-6. PubMed ID: 22785050
[TBL] [Abstract][Full Text] [Related]
44. Treatment of hypertension based on measurement of blood pressure variability: lessons from animal studies.
Su DF
Curr Opin Cardiol; 2006 Sep; 21(5):486-91. PubMed ID: 16900013
[TBL] [Abstract][Full Text] [Related]
45. Prehypertensive renin-angiotensin-aldosterone system blockade in spontaneously hypertensive rats ameliorates the loss of long-term vascular function.
Baumann M; Megens R; Bartholome R; Dolff S; van Zandvoort MA; Smits JF; Struijker-Boudier HA; De Mey JG
Hypertens Res; 2007 Sep; 30(9):853-61. PubMed ID: 18037779
[TBL] [Abstract][Full Text] [Related]
46. Discordant effects of beta-blockade on central aortic systolic and brachial systolic blood pressure: considerations beyond the cuff.
Epstein BJ; Anderson S
Pharmacotherapy; 2007 Sep; 27(9):1322-33. PubMed ID: 17723086
[TBL] [Abstract][Full Text] [Related]
47. Resistant hypertension: a methodological approach to diagnosis and treatment.
Tamimi NA
Saudi J Kidney Dis Transpl; 2007 Sep; 18(3):337-45. PubMed ID: 17679742
[TBL] [Abstract][Full Text] [Related]
48. Aldosterone inhibition reduces the risk of sudden cardiac death in patients with heart failure.
Anand K; Mooss AN; Mohiuddin SM
J Renin Angiotensin Aldosterone Syst; 2006 Mar; 7(1):15-9. PubMed ID: 17083069
[TBL] [Abstract][Full Text] [Related]
49. Aldosterone-induced cardiac damage: focus on blood pressure independent effects.
Schmidt BM; Schmieder RE
Am J Hypertens; 2003 Jan; 16(1):80-6. PubMed ID: 12517689
[TBL] [Abstract][Full Text] [Related]
50. Should we consider aldosterone as the primary screening target for preventing cardiovascular events?
Francis GS; Tang WH
J Am Coll Cardiol; 2005 Apr; 45(8):1249-50. PubMed ID: 15837257
[No Abstract] [Full Text] [Related]
51. Aldosteronism revisited: perspectives on less well-recognized actions of aldosterone.
Weber KT
J Lab Clin Med; 2003 Aug; 142(2):71-82. PubMed ID: 12960953
[TBL] [Abstract][Full Text] [Related]
52. Aldosterone revisited.
Kleta R; O'Brien K
N Engl J Med; 2004 Nov; 351(20):2131-3; author reply 2131-3. PubMed ID: 15543661
[No Abstract] [Full Text] [Related]
53. Aldosterone as a modulator of immunity: implications in the organ damage.
Herrada AA; Campino C; Amador CA; Michea LF; Fardella CE; Kalergis AM
J Hypertens; 2011 Sep; 29(9):1684-92. PubMed ID: 21826023
[TBL] [Abstract][Full Text] [Related]
54. [Present day hypertension research is determined by cell biology and genetics. Modern therapies protect the organs].
Haller H; Schrader J
MMW Fortschr Med; 2004 Nov; 146(47):39-40. PubMed ID: 15624655
[No Abstract] [Full Text] [Related]
55. [Aldosterone antagonists and a direct renin inhibitor in the treatment of the metabolic syndrome].
Tamura N; Nakao K
Nihon Rinsho; 2011 Jan; 69 Suppl 1():592-6. PubMed ID: 21766666
[No Abstract] [Full Text] [Related]
56. Proceedings of the symposium Mineralocorticoids in Essential and Secondary Hypertension. Newport Beach, California, February 28, 1982.
Clin Exp Hypertens A; 1982; 4(9-10):1447-934. PubMed ID: 7139969
[No Abstract] [Full Text] [Related]
57. [The importance of aldosterone in the development of edema and hypertension].
Ratner NA; Gerasimova EN
Klin Med (Mosk); 1966 Jul; 44(7):13-20. PubMed ID: 5956281
[No Abstract] [Full Text] [Related]
58. Aldosterone revisited.
Haddy FJ
N Engl J Med; 2004 Nov; 351(20):2131-3; author reply 2131-3. PubMed ID: 15537915
[No Abstract] [Full Text] [Related]
59. [Aldosterone production of the adrenal gland in experimental renal hypertension].
WEISZ P; GLAZ E; PURJESZ I; RITTER L
Z Gesamte Inn Med; 1960 Mar; 15():271-3. PubMed ID: 13843793
[No Abstract] [Full Text] [Related]
60. New frontiers in aldosterone/mineralocorticoid biology: a reemerging force in target organ damage and hypertension.
Kurtz TW; Catanzaro DF
Am J Hypertens; 2001 Dec; 14(12):1276-7. PubMed ID: 11775139
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
